---
figid: PMC11694028__fphar-15-1505027-g003
figtitle: Interaction of FBXW7 with signaling pathways and key molecules in gastrointestinal
  cancers
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11694028
filename: fphar-15-1505027-g003.jpg
figlink: /pmc/articles/PMC11694028/figure/F3/
number: F3
caption: Interaction of FBXW7 with signaling pathways and key molecules in gastrointestinal
  cancers. (1) FBXW7 directly targets EGFR and SHOC2, blocking the activation of the
  MAPK signaling pathway. ERK1/2 promotes FBXW7 phosphorylation, further activating
  the MAPK pathway. (2) FBXW7 directly targets β-catenin, inhibiting the activation
  of the Wnt/β-catenin signaling pathway. (3) FBXW7 directly targets Nox1, PTEN, and
  mTOR, inhibiting the activation of the Akt/mTOR signaling pathway. (4) FBXW7 degrades
  MCL-1, thereby promoting apoptosis. (5) FBXW7 targets Notch1/NICD, inhibiting MAPK
  signaling. The degradation of Notch1/NICD inhibits cell proliferation. (6) FBXW7
  mediates Cyclin E degradation, maintaining a normal cell cycle. (7) MicroRNA-770,
  MiR-92a-3p, MiR-27a, and MiR-223 inhibit FBXW7 expression
papertitle: 'FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic
  prospects'
reftext: Wanqing Wang, et al. Front Pharmacol. 2024;15(NA).
year: '2024'
doi: 10.3389/fphar.2024.1505027
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: FBXW7 | gastrointestinal cancers | molecular mechanism | therapeutic strategies
  | biomarker
automl_pathway: 0.9472913
figid_alias: PMC11694028__F3
figtype: Figure
redirect_from: /figures/PMC11694028__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11694028__fphar-15-1505027-g003.html
  '@type': Dataset
  description: Interaction of FBXW7 with signaling pathways and key molecules in gastrointestinal
    cancers. (1) FBXW7 directly targets EGFR and SHOC2, blocking the activation of
    the MAPK signaling pathway. ERK1/2 promotes FBXW7 phosphorylation, further activating
    the MAPK pathway. (2) FBXW7 directly targets β-catenin, inhibiting the activation
    of the Wnt/β-catenin signaling pathway. (3) FBXW7 directly targets Nox1, PTEN,
    and mTOR, inhibiting the activation of the Akt/mTOR signaling pathway. (4) FBXW7
    degrades MCL-1, thereby promoting apoptosis. (5) FBXW7 targets Notch1/NICD, inhibiting
    MAPK signaling. The degradation of Notch1/NICD inhibits cell proliferation. (6)
    FBXW7 mediates Cyclin E degradation, maintaining a normal cell cycle. (7) MicroRNA-770,
    MiR-92a-3p, MiR-27a, and MiR-223 inhibit FBXW7 expression
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EGFR
  - CTNNB1
  - GSK3A
  - GSK3B
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - KRAS
  - HRAS
  - NRAS
  - SHOC2
  - FBXW7
  - MIR182
  - CCNE1
  - CCNE2
  - BRAF
  - MAP2K2
  - MAP2K1
  - MAPK3
  - MAPK1
  - MTG1
  - NOTCH1
  - ANXA2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MIR223
  - PTEN
  - MCL1
  - BAX
  - BAK1
  - CDK1
  - CDK2
  - MAP4
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - NOX1
  - HNF4A
  - CSHL1
  - RBPJ
  - SMPX
  - EGF
  - Ras
  - GTP
  - Nucleus
---
